Opravil, Milos; Klimkait, Thomas; Louvel, Severine; Wolf, Eva; Battegay, Manuel; Fux, Christoph A; Bernasconi, Enos; Vogel, Martin; Speck, Roberto; Weber, Rainer; Swiss HIV Cohort Study, (2010). Prior therapy influences the efficacy of lamivudine monotherapy in patients with lamivudine-resistant HIV-1 infection. Journal of acquired immune deficiency syndromes JAIDS, 54(1), pp. 51-8. Philadelphia, Pa.: Lippincott Williams & Wilkins 10.1097/QAI.0b013e3181bef889
Full text not available from this repository. (Request a copy)The M184V mutation decreases the replication capacity of HIV-1. This prospective study aimed to characterize the virologic and immunologic changes during monotherapy with lamivudine (3TC) in patients with limited options for a fully suppressive new therapy.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology |
UniBE Contributor: |
Fux, Christoph Andreas |
ISSN: |
0894-9255 |
Publisher: |
Lippincott Williams & Wilkins |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:13 |
Last Modified: |
05 Dec 2022 14:02 |
Publisher DOI: |
10.1097/QAI.0b013e3181bef889 |
PubMed ID: |
19838125 |
Web of Science ID: |
000277001500007 |
URI: |
https://boris.unibe.ch/id/eprint/2717 (FactScience: 205585) |
Actions (login required)
 |
Edit item |